✦ LIBER ✦

Botulinum toxin treatment in atypical parkinsonian disorders associated with disabling focal dystonia

✍ Scribed by J. Müller; G. K. Wenning; J. Wissel; K. Seppi; W. Poewe

Book ID: 106096419
Publisher: Springer
Year: 2002
Tongue: English
Weight: 179 KB
Volume: 249
Category: Article
ISSN: 0340-5354
DOI: 10.1007/s004150200009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Botulinum toxin treatment in patients wi

Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group

✍ A. Berardelli; A. Formica; B. Mercuri; G. Abbruzzese; A. Agnoli; R. Agostino; T. 📂 Article 📅 1993 🏛 Springer Milan 🌐 English ⚖ 535 KB

Five-year experience in the treatment of

Five-year experience in the treatment of focal movement disorders with low-dose dysportTM botulinum toxin

✍ P. Van Den Bergh; J. Francart; S. Mourin; P. Kollmann; E. C. Laterre 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 987 KB

We report the results of botulinum toxin type A (Dysport"", Porton Products, UK) treatment over 5 years in 107 patients with blepharospasm, Meige's syndrome, oromandibular dystonia, hemifacial spasm, cervical dystonia, and writer's cramp. Electromyography was used to localize dystonic muscles and gu